RSNA publishes new radiology journal

The Radiological Society of North America (RSNA) has published their first issue of Radiology: Imaging Cancer, a new online journal dedicated to the latest in cancer imaging.

The journal is the newest of three online publications RSNA has added to its offerings. Gary D. Luker, MD, an editor of the new publication said it will also cover the “best clinical and translational cancer imaging studies across organ systems and modalities,” which includes new technological developments.

"We are delighted that RSNA has started this journal as a new venue for scientists and physicians to disseminate and learn the latest discoveries in cancer imaging,” Luker, professor of radiology, biomedical engineering, microbiology and immunology, and associate chair for clinical research in the department of radiology at Michigan Medicine in Ann Arbor, said in a statement.

The first articles published in Radiology: Imaging Cancer include: "Comparative Benefit-to–Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis" and "Let's Get Real about Molecular Breast Imaging and Radiation Risk,” among many others.

"We want Radiology: Imaging Cancer to become a 'must-read' journal for anyone working at the intersection of imaging and cancer," Luker added. "Through the forum provided by the journal, we look forward to engaging RSNA members and a broad community of researchers and clinicians who are merging imaging and cancer to improve diagnosis, treatment and quality of life for patients with cancer."

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.